Intended Cooperation
CheckImmune aims to collaborate directly with pharma and biotech companies to deliver advanced biomarker analyses for clinical development. In addition, the company seeks strategic partnerships with CROs and early-stage biotechs to support complex studies and proof-of-concept projects, particularly within US life science clusters.
Products/Services
CheckImmune offers a range of advanced biomarker solutions for clinical development that includes:
- Biomarker strategy consulting and selection/validation of drug candidates
- Proof-of-concept studies and biomarker-based therapy monitoring in clinical trials
- Advanced laboratory services using technologies such as flow cytometry, proteomics, and single-cell analysis
- Data analysis and scientific/medical interpretation to support drug development decisions
CheckImmune GmbH is a Berlin-based innovative biomarker service company and a spin-off from Charité-Universitätsmedizin Berlin, specializing in immunology-driven analyses for clinical development.
The company provides end-to-end biomarker solutions, including consulting, laboratory services, and scientific data interpretation to support drug development and clinical trials. With a strong focus on immunotherapeutics, CheckImmune leverages advanced technologies such as flow cytometry, proteomics, and single-cell multiomics to deliver high-quality, GCLP-compliant data.
- Dr. Levent Akyüz
- levent.akyuez@checkimmune.com
- https://checkimmune.com
Arrange an appointment for an
initial consultation
Are you interested in one of our projects? Then book a consultation now. We will be happy to present the project to you.
Philip Okito
General Manager and Co-Founder
- service@traide.de
- + 4922193544511
- Hohenstaufenring 42, 50674 Köln
free of charge & without obligation